A potential role for Elf-1 in terminal transferase gene regulation.
The terminal deoxynucleotidyltransferase (TdT) gene represents an attractive model for the analysis of gene regulation during an early phase of lymphocyte development. In previous studies, we identified a DNA element, termed D', which is essential for TdT promoter activity in immature lymphocytes, and two classes of D'-binding factors, Ikaros proteins and Ets proteins. Here, we report a detailed mutant analysis of the D' element which suggests that an Ets protein, rather than an Ikaros protein, activates TdT transcription. Since multiple Ets proteins are expressed in developing lymphocytes and are capable of binding to the D' element, DNA affinity chromatography was used to determine if one of the Ets proteins might bind to the D' element with a uniquely high affinity, thereby implicating that protein as a potential TdT activator. Indeed, one binding activity was greatly enriched in the high-salt eluates from a D' affinity column. Peptide microsequencing revealed that the enriched protein was Elf-1. Immunoblot analyses confirmed that in nuclear extracts, Elf-1 has a significantly higher affinity for the D' sequence than does another Ets protein, Ets-1. Transactivation and expression studies support the hypothesis that Elf-1 activates TdT transcription in immature T and B cells. Finally, a D' mutation which selectively reduces Elf-1 binding, but not the binding of other Ets proteins, was found to greatly reduce TdT promoter activity. Although Elf-1 previously had been implicated in the inducible activation of genes in mature T and B cells, our results suggest that it also plays an important role in regulating genes during an early phase of lymphocyte development.
Department of Microbiology and Immunology, UCLA School of Medicine, Los Angeles, California 90095-1662, USA.
P
P
Ernst
K
K
Hahm
L
L
Trinh
J N
JN
Davis
M F
MF
Roussel
C W
CW
Turck
S T
ST
Smale
D000595:Amino Acid Sequence; D000818:Animals; D001402:B-Lymphocytes / Q000201:enzymology; D001483:Base Sequence; D001665:Binding Sites; D002460:Cell Line; D002467:Cell Nucleus / Q000378:metabolism; D004253:DNA Nucleotidylexotransferase / Q000096:biosynthesis* / Q000235:genetics; D036383:Ephrin-A2; D015971:Gene Expression Regulation, Enzymologic; D006801:Humans; D007668:Kidney; D008214:Lymphocytes / Q000201:enzymology; D051379:Mice; D016297:Mutagenesis, Site-Directed; D010446:Peptide Fragments / Q000737:chemistry; D011401:Promoter Regions, Genetic; D011506:Proteins / Q000378:metabolism*; D011993:Recombinant Fusion Proteins / Q000096:biosynthesis; D013601:T-Lymphocytes / Q000201:enzymology*; D014158:Transcription, Genetic; D014162:Transfection
D036383:Ephrin-A2; D010446:Peptide Fragments; D011506:Proteins; D011993:Recombinant Fusion Proteins; D004253:DNA Nucleotidylexotransferase